Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
Garcia-Prieto CA, Villanueva L, Bueno-Costa A, Davalos V, González-Navarro EA, Juan M, Urbano-Ispizua Á, Delgado J, Ortiz-Maldonado V, Del Bufalo F, Locatelli F, Quintarelli C, Sinibaldi M, Soler M, Castro de Moura M, Ferrer G, Urdinguio RG, Fernandez AF, Fraga MF, Bar D, Meir A, Itzhaki O, Besser MJ, Avigdor A, Jacoby E, Esteller M. Garcia-Prieto CA, et al. Among authors: avigdor a. J Natl Cancer Inst. 2022 Mar 8;114(3):436-445. doi: 10.1093/jnci/djab194. J Natl Cancer Inst. 2022. PMID: 34581788 Free PMC article.
CAR T cells induce a complete response in refractory Burkitt Lymphoma.
Avigdor A, Shouval R, Jacoby E, Davidson T, Shimoni A, Besser M, Nagler A. Avigdor A, et al. Bone Marrow Transplant. 2018 Dec;53(12):1583-1585. doi: 10.1038/s41409-018-0235-0. Epub 2018 May 24. Bone Marrow Transplant. 2018. PMID: 29795432 No abstract available.
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia.
Jacoby E, Bielorai B, Avigdor A, Itzhaki O, Hutt D, Nussboim V, Meir A, Kubi A, Levy M, Zikich D, Zeltzer LA, Brezinger K, Schachter J, Nagler A, Besser MJ, Toren A. Jacoby E, et al. Among authors: avigdor a. Am J Hematol. 2018 Dec;93(12):1485-1492. doi: 10.1002/ajh.25274. Epub 2018 Sep 26. Am J Hematol. 2018. PMID: 30187944 Free article. Clinical Trial.
Early and late hematologic toxicity following CD19 CAR-T cells.
Fried S, Avigdor A, Bielorai B, Meir A, Besser MJ, Schachter J, Shimoni A, Nagler A, Toren A, Jacoby E. Fried S, et al. Among authors: avigdor a. Bone Marrow Transplant. 2019 Oct;54(10):1643-1650. doi: 10.1038/s41409-019-0487-3. Epub 2019 Feb 26. Bone Marrow Transplant. 2019. PMID: 30809033
Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells.
Danylesko I, Jacoby E, Yerushalmi R, Shem-Tov N, Besser MJ, Vernitsky H, Marcu-Malina V, Shimoni A, Avigdor A, Nagler A. Danylesko I, et al. Among authors: avigdor a. Leukemia. 2020 Jul;34(7):1939-1942. doi: 10.1038/s41375-020-0719-y. Epub 2020 Jan 24. Leukemia. 2020. PMID: 31980731 No abstract available.
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients.
Itzhaki O, Jacoby E, Nissani A, Levi M, Nagler A, Kubi A, Brezinger K, Brayer H, Zeltzer LA, Rozenbaum M, Vernitsky H, Markel G, Toren A, Avigdor A, Schachter J, Besser MJ. Itzhaki O, et al. Among authors: avigdor a. J Immunother Cancer. 2020 Mar;8(1):e000148. doi: 10.1136/jitc-2019-000148. J Immunother Cancer. 2020. PMID: 32152221 Free PMC article. Clinical Trial.
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma.
Danylesko I, Shouval R, Shem-Tov N, Yerushalmi R, Jacoby E, Besser MJ, Shimoni A, Davidson T, Beider K, Mevorach D, Fried S, Nagler A, Avigdor A. Danylesko I, et al. Among authors: avigdor a. Bone Marrow Transplant. 2021 May;56(5):1134-1143. doi: 10.1038/s41409-020-01156-y. Epub 2020 Dec 3. Bone Marrow Transplant. 2021. PMID: 33268830 Free PMC article. Clinical Trial.
CAR T cells for the long run in aggressive B-cell lymphoma.
Jacoby E, Avigdor A. Jacoby E, et al. Among authors: avigdor a. Lancet Oncol. 2021 Oct;22(10):1347-1348. doi: 10.1016/S1470-2045(21)00412-5. Epub 2021 Sep 10. Lancet Oncol. 2021. PMID: 34516955 No abstract available.
134 results